Deep Vein ThrombosisPhase 1NCT00114608
Venous Blood Flow Velocity: Electrical Foot Stimulation Compared to Intermittent Pneumatic Compression of the Foot
A Phase 1 study testing The Focus™ Neuromuscular Stimulation System in people with Deep Vein Thrombosis and Pulmonary Embolism, run by University at Buffalo at 1 site in United States.
Trial summary
Electrical stimulation of the foot can increase blood flow out of the leg. This increased blood flow can prevent blood clots from forming in the leg veins. Blood clots in the leg veins can break off and form life-threatening blood clots in the lungs. Read more about this study
- Who is it for?
- Ages 50 to 80 yearsHealthy volunteers can take part
- Conditions the study is for
- Deep Vein Thrombosis, Pulmonary Embolism
- What is being tested?
- The Focus™ Neuromuscular Stimulation System
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 40 participants
- Where
- 1 siteUnited States
- Study dates
- Jun 2005to Jul 2007
- Phase
- Phase 1
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 50 to 80 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Healthy volunteers
Who cannot join
- Venous or arterial disease of the lower limbs
- Cardiac pacemaker
- Known allergy to materials of surface electrodes
- Neurologic disorder
- Lower extremity fracture history
- History of joint replacement surgery
- Anticoagulation therapy other than aspirin
Trial locations and contacts
1 site in 1 country.
About this study
Electrical stimulation of the foot can increase blood flow out of the leg. This increased blood flow can prevent blood clots from forming in the leg veins.
Blood clots in the leg veins can break off and form life-threatening blood clots in the lungs.
Intermittent external pneumatic (air) compression of the foot is already used to increase blood flow in at risk patients.
Hypothesis: Electrical stimulation of the foot increases blood flow out of the legs to the same degree as intermittent external pneumatic (air) compression of the foot.
Read the detailed description
ABSTRACT Background: Venous stasis caused by immobility is an important risk factor for venous thromboembolic disease. This is especially true for orthopedic patients with multiple trauma and those undergoing other orthopedic procedures. A safe and convenient method for reducing venous stasis would be useful for preventing venous thrombosis in patients while in hospital and particularly after discharge during rehabilitation. In a prior study, we demonstrated that electrical stimulation of the foot was a safe and convenient method for counteracting venous stasis. In this study, we compare the effects on venous blood flow of intermittent pneumatic compression, an established method, to electrical stimulation of the foot.
Methods: 40 healthy volunteers aged 50 - 80 were seated for 4 hours during which they received mild electrical stimulation of the sole of the foot (plantar plexus of muscles) or intermittent pneumatic compression. Popliteal and femoral venous blood flow velocities were measured via Doppler ultrasound. Blood flow in the non-stimulated or non-compressed lower extremity served as a simultaneous control. Subjects completed a questionnaire regarding their acceptance and tolerance of both treatments.
INTRODUCTION Venous thrombosis and pulmonary embolism or venous thromboembolism (VTE) are important complications of medical and surgical conditions that are associated with prolonged immobilization. This is especially true for orthopedic patients with multiple trauma and those undergoing other orthopedic procedures. Immobilization is also a major contributor to the increased risk of VTE associated with prolonged air travel.
Despite good evidence that prophylaxis is effective, there is widespread under utilization of prophylaxis for VTE following major surgical procedures as well as medical conditions that produce weakness or prolonged bed rest. There is also good evidence that the risk of VTE continues for weeks after major orthopedic as well as other types of surgery. It is now recognized that VTE occurring in the hospital and outside the hospital setting is a single entity and that extended prophylaxis with anticoagulants reduces the risk.
Anticoagulant prophylaxis after hospital discharge although indicated in certain high risk groups is inconvenient since the recommended methods, LMWH and fondaparinux must be administered by subcutaneous injection and warfarin requires laboratory monitoring.
Physical methods that increase blood flow in the leg veins are effective for reducing venous thrombosis in high-risk hospitalized medical and surgical patients. These methods include: high intensity electrical calf stimulation during surgery, graduated compression stockings and intermittent pneumatic compression of the leg or foot. Of these, only graduated compression stockings, which are not very effective, can be used after hospital discharge. Graduated compression stockings, however, cannot be adapted to fit all leg shapes, may be improperly applied, have a tendency to slip down the leg and are found to be uncomfortable by many patients. High intensity electrical calf muscle stimulation is painful and can only be used during general anesthesia. AC powered external pneumatic compression can only be used while the patient is fully immobilized. Thus, alternative convenient methods are needed which can be used both in the immobilized and partly mobile patient, particularly after hospital discharge.
We have attempted to overcome the limitations of currently available physical devices by using mild electrical stimulation of the plantar muscles of the feet. Each electrical discharge elicits a foot twitch that causes the intrinsic foot muscles to contract. This contraction compresses the plantar plexus of veins, thereby increasing venous velocity in the popliteal and femoral veins that is transmitted proximally up the leg veins.
Our plantar foot stimulation device is powered by a 9-volt battery and small enough to be inserted into a sock. It has the potential to be worn while a patient is immobile, standing or walking, and therefore is suitable for use both during the initial period of immobilization and throughout convalescence.
In an earlier study we reported that mild electrical stimulation of the plantar foot muscles caused an increase in blood flow comparable to that produced by direct calf stimulation.
The aim of this new study is to determine if, over a 4 hour period, mild electrical stimulation of the plantar foot muscles increases venous blood flow velocity to the same degree as intermittent pneumatic compression (IPC) of the leg in both obese and non-obese subjects.
MATERIALS AND METHODS IRB approval and informed consent was obtained from all subjects. Forty healthy subjects (N = 40) between the ages of 50 to 80 participated in the study. Half of the subjects (N = 20) were non-obese with a Body Mass Index (BMI) < 30. The other half of the subjects (N = 20) were obese with a BMI > 30. Exclusion criterion included a prior history of deep vein thrombosis or pulmonary embolism, or any trauma or surgery involving any part of the lower extremities.
Subjects were studied over 2 sessions. At each session, subjects received either electrical foot stimulation or intermittent pneumatic compression of one foot. The other lower extremity served as a control. Subjects received either therapy at one session and the other therapy at a second session at least 48 hours later. The right or left leg of each subject was randomly assigned as the same control leg for both studies. The type of therapy given at the first session was also randomly assigned.
The study otherwise followed the protocol used in our initial study of electrical foot stimulation. Subjects were seated for 4 hours in chairs placed at a fixed distance apart. They were constantly monitored throughout the study to ensure that they remained seated. Subjects were allowed to use a bathroom located several feet away only twice during the 4 hour period. During the 4 hour study period subjects were offered a maximum of 16 ounces of fluid and a normal lunch.
Electrical foot stimulation was produced by surface electrodes placed on the sole of the foot over the plantar muscle group. Electrical stimulation was delivered by the Focus™ Neuromuscular Stimulation System, Empi, Inc. (St. Paul, MN.) The crucial stimulus parameters were: biphasic symmetrical square wave at 50 pulses per second, phase duration of 300 microseconds, a starting ramp up time of 2 seconds and a finishing ramp down time of 2 seconds per stimulation cycle, and a stimulation cycle of 12 seconds "on" and 48 seconds "off" per minute. Stimulation was increased to an intensity just sufficient to create a slight visible muscle twitch. This level of intensity caused no evident discomfort in any of the subjects in our first study. Subjects were continually monitored throughout this study for any indication of discomfort.
Intermittent pneumatic compression of the leg consisted of external intermittent pneumatic compression with a knee high device. A Tyco Healthcare Kendall Novamedix A-V impulse system® Model 6060 (Mansfield, MA 02048) was used. Operating parameters were: 130mmHg impulse pressure with a 3 second impulse duration; "Program Preset 1" for deep vein thrombosis prophylaxis. The compression followed the approved standard patient protocol used at our institution detailed in "Utilization of Intermittent Pneumatic Compression (IPC) Stockings for DVT Prophylaxis".
Popliteal and femoral venous peak blood flow velocities were measured bilaterally using a Doppler ultrasound device at 0, 15, 120, and 240 minutes. The same ultrasound technician obtained all Doppler studies on all subjects throughout the study. All Doppler tracings were be read by the same independent reader in a blinded fashion. Immediately following completion of each 4 hour session of electrical foot stimulation or intermittent pneumatic compression, subjects were asked to complete a brief questionnaire regarding their acceptance and tolerance of electrical stimulation or intermittent pneumatic compression.
STATISTICAL METHODS This study utilized a repeated measures design with two within group factors: time to measurement, and stimulation (stimulation, control). Stimulation groups [electrical foot stimulation and intermittent pneumatic compression (IPC)] were not independent. Blood flow measurements (at time = 120, 240) were analyzed with t tests and a mixed model. Within the mixed model, the group effect is a fixed effect, and the subject parameter is a random effect. The primary research question was the non-inferiority of the experimental treatment (electrical foot stimulation) relative to standard treatment (intermittent pneumatic compression). The non-inferiority index was 5.0 cm/sec; this index was formulated prior to analysis. The questionnaire results were analyzed using Fisher's Exact test. P-values that were less than 0.05 were considered to be statistically significant. All analyses were done with SAS 9.1, Cary, NC.
- Conditions
- Deep Vein Thrombosis, Pulmonary Embolism
- Being tested
- The Focus™ Neuromuscular Stimulation System
- Keywords
- Electrical foot stimulation, Intermittent pneumatic compression, Venous thromboembolism, Immobilization, Total hip replacement, Prolonged travel, Venous thromboembolic disease (VTE), Deep vein thrombosis (DVT), Pulmonary embolism (PE)
- Medical subject headings
- Venous Thrombosis, Pulmonary Embolism, Venous Thromboembolism
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
The Focus™ Neuromuscular Stimulation SystemDevice
Electrical foot stimulation was produced by surface electrodes placed on the sole of the foot over the plantar muscle group. Electrical stimulation was delivered by The Focus™ Neuromuscular Stimulation System, Empi, Inc. (St. Paul, MN.) The crucial stimulus parameters were: biphasic symmetrical square wave at 50 pulses per second, phase duration of 300 microseconds, a starting ramp up time of 2 seconds and a finishing ramp down time of 2 seconds per stimulation cycle, and a stimulation cycle of 12 seconds "on" and 48 seconds "off" per minute. Stimulation was increased to an intensity just sufficient to create a slight visible muscle twitch. This level of intensity caused no evident discomfort in any of the subjects in our first study. Subjects were continually monitored throughout this study for any indication of discomfort.The Focus™ Neuromuscular Stimulation System created electrical stimulation of the plantar foot muscles.
| Study group | Role | What they receive |
|---|---|---|
| 1 | Experimental | Electrical foot stimulation Receives: Device: The Focus™ Neuromuscular Stimulation System |
What is being measured
The primary outcome is the main question the study is designed to answer.
Doppler venous blood flow velocity changes over 4 hours
Measured: Two, 4 hour sessions
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Jun 2005 (estimated)
- Study startJun 2005
- Primary completionJul 2007
- Study completionJul 2007
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Deep Vein ThrombosisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 1
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 40 participants (actual)
Sponsor and investigators
- Lead sponsor
- University at Buffalo
- Sponsor type
- University, hospital or other
- Investigators
- Robert E Kaplan, MD, Principal investigator, University at Buffalo School of Medicine and Biomedical SciencesJames J Czyrny, MD, Principal investigator, University at Buffalo School of Medicine and Biomedical Sciences
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00114608
- Sponsor's protocol ID
- STUDY # 2
- Status last verified
- Mar 2008
- First submitted
- 15 Jun 2005
- Last updated
- 11 Mar 2008
- Results posted
- No
- Data monitoring committee
- Yes
Publications
Kaplan RE, Czyrny JJ, Fung TS, Unsworth JD, Hirsh J. Electrical foot stimulation and implications for the prevention of venous thromboembolic disease. Thromb Haemost. 2002 Aug;88(2):200-4.
PubMed 12195689
Study at a glance
From the registry record, last updated by the sponsor on 11 Mar 2008. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Venous Blood Flow Velocity: Electrical Foot Stimulation Compared to Intermittent Pneumatic Compression of the Foot
- ClinicalTrials.gov ID
- NCT00114608
- Acronym / sponsor ID
- STUDY # 2
- Conditions
- Deep Vein Thrombosis, Pulmonary Embolism
- Keywords
- Electrical foot stimulation, Intermittent pneumatic compression, Venous thromboembolism, Immobilization, Total hip replacement, Prolonged travel, Venous thromboembolic disease (VTE), Deep vein thrombosis (DVT)
- Phase
- Phase 1
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 40 participants (actual)
- Lead sponsor
- University at BuffaloUniversity, hospital or other
- Study start
- Jun 2005
- Primary completion
- Jul 2007 (actual)
- Study completion
- Jul 2007 (actual)
- First posted
- 16 Jun 2005 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Electrical stimulation of the foot can increase blood flow out of the leg. This increased blood flow can prevent blood clots from forming in the leg veins.
Blood clots in the leg veins can break off and form life-threatening blood clots in the lungs.
Intermittent external pneumatic (air) compression of the foot is already used to increase blood flow in at risk patients.
Hypothesis: Electrical stimulation of the foot increases blood flow out of the legs to the same degree as intermittent external pneumatic (air) compression of the foot.
Detailed description
ABSTRACT Background: Venous stasis caused by immobility is an important risk factor for venous thromboembolic disease. This is especially true for orthopedic patients with multiple trauma and those undergoing other orthopedic procedures. A safe and convenient method for reducing venous stasis would be useful for preventing venous thrombosis in patients while in hospital and particularly after discharge during rehabilitation. In a prior study, we demonstrated that electrical stimulation of the foot was a safe and convenient method for counteracting venous stasis. In this study, we compare the effects on venous blood flow of intermittent pneumatic compression, an established method, to electrical stimulation of the foot.
Methods: 40 healthy volunteers aged 50 - 80 were seated for 4 hours during which they received mild electrical stimulation of the sole of the foot (plantar plexus of muscles) or intermittent pneumatic compression. Popliteal and femoral venous blood flow velocities were measured via Doppler ultrasound. Blood flow in the non-stimulated or non-compressed lower extremity served as a simultaneous control. Subjects completed a questionnaire regarding their acceptance and tolerance of both treatments.
INTRODUCTION Venous thrombosis and pulmonary embolism or venous thromboembolism (VTE) are important complications of medical and surgical conditions that are associated with prolonged immobilization. This is especially true for orthopedic patients with multiple trauma and those undergoing other orthopedic procedures. Immobilization is also a major contributor to the increased risk of VTE associated with prolonged air travel.
Despite good evidence that prophylaxis is effective, there is widespread under utilization of prophylaxis for VTE following major surgical procedures as well as medical conditions that produce weakness or prolonged bed rest. There is also good evidence that the risk of VTE continues for weeks after major orthopedic as well as other types of surgery. It is now recognized that VTE occurring in the hospital and outside the hospital setting is a single entity and that extended prophylaxis with anticoagulants reduces the risk.
Anticoagulant prophylaxis after hospital discharge although indicated in certain high risk groups is inconvenient since the recommended methods, LMWH and fondaparinux must be administered by subcutaneous injection and warfarin requires laboratory monitoring.
Physical methods that increase blood flow in the leg veins are effective for reducing venous thrombosis in high-risk hospitalized medical and surgical patients. These methods include: high intensity electrical calf stimulation during surgery, graduated compression stockings and intermittent pneumatic compression of the leg or foot. Of these, only graduated compression stockings, which are not very effective, can be used after hospital discharge. Graduated compression stockings, however, cannot be adapted to fit all leg shapes, may be improperly applied, have a tendency to slip down the leg and are found to be uncomfortable by many patients. High intensity electrical calf muscle stimulation is painful and can only be used during general anesthesia. AC powered external pneumatic compression can only be used while the patient is fully immobilized. Thus, alternative convenient methods are needed which can be used both in the immobilized and partly mobile patient, particularly after hospital discharge.
We have attempted to overcome the limitations of currently available physical devices by using mild electrical stimulation of the plantar muscles of the feet. Each electrical discharge elicits a foot twitch that causes the intrinsic foot muscles to contract. This contraction compresses the plantar plexus of veins, thereby increasing venous velocity in the popliteal and femoral veins that is transmitted proximally up the leg veins.
Our plantar foot stimulation device is powered by a 9-volt battery and small enough to be inserted into a sock. It has the potential to be worn while a patient is immobile, standing or walking, and therefore is suitable for use both during the initial period of immobilization and throughout convalescence.
In an earlier study we reported that mild electrical stimulation of the plantar foot muscles caused an increase in blood flow comparable to that produced by direct calf stimulation.
The aim of this new study is to determine if, over a 4 hour period, mild electrical stimulation of the plantar foot muscles increases venous blood flow velocity to the same degree as intermittent pneumatic compression (IPC) of the leg in both obese and non-obese subjects.
MATERIALS AND METHODS IRB approval and informed consent was obtained from all subjects. Forty healthy subjects (N = 40) between the ages of 50 to 80 participated in the study. Half of the subjects (N = 20) were non-obese with a Body Mass Index (BMI) < 30. The other half of the subjects (N = 20) were obese with a BMI > 30. Exclusion criterion included a prior history of deep vein thrombosis or pulmonary embolism, or any trauma or surgery involving any part of the lower extremities.
Subjects were studied over 2 sessions. At each session, subjects received either electrical foot stimulation or intermittent pneumatic compression of one foot. The other lower extremity served as a control. Subjects received either therapy at one session and the other therapy at a second session at least 48 hours later. The right or left leg of each subject was randomly assigned as the same control leg for both studies. The type of therapy given at the first session was also randomly assigned.
The study otherwise followed the protocol used in our initial study of electrical foot stimulation. Subjects were seated for 4 hours in chairs placed at a fixed distance apart. They were constantly monitored throughout the study to ensure that they remained seated. Subjects were allowed to use a bathroom located several feet away only twice during the 4 hour period. During the 4 hour study period subjects were offered a maximum of 16 ounces of fluid and a normal lunch.
Electrical foot stimulation was produced by surface electrodes placed on the sole of the foot over the plantar muscle group. Electrical stimulation was delivered by the Focus™ Neuromuscular Stimulation System, Empi, Inc. (St. Paul, MN.) The crucial stimulus parameters were: biphasic symmetrical square wave at 50 pulses per second, phase duration of 300 microseconds, a starting ramp up time of 2 seconds and a finishing ramp down time of 2 seconds per stimulation cycle, and a stimulation cycle of 12 seconds "on" and 48 seconds "off" per minute. Stimulation was increased to an intensity just sufficient to create a slight visible muscle twitch. This level of intensity caused no evident discomfort in any of the subjects in our first study. Subjects were continually monitored throughout this study for any indication of discomfort.
Intermittent pneumatic compression of the leg consisted of external intermittent pneumatic compression with a knee high device. A Tyco Healthcare Kendall Novamedix A-V impulse system® Model 6060 (Mansfield, MA 02048) was used. Operating parameters were: 130mmHg impulse pressure with a 3 second impulse duration; "Program Preset 1" for deep vein thrombosis prophylaxis. The compression followed the approved standard patient protocol used at our institution detailed in "Utilization of Intermittent Pneumatic Compression (IPC) Stockings for DVT Prophylaxis".
Popliteal and femoral venous peak blood flow velocities were measured bilaterally using a Doppler ultrasound device at 0, 15, 120, and 240 minutes. The same ultrasound technician obtained all Doppler studies on all subjects throughout the study. All Doppler tracings were be read by the same independent reader in a blinded fashion. Immediately following completion of each 4 hour session of electrical foot stimulation or intermittent pneumatic compression, subjects were asked to complete a brief questionnaire regarding their acceptance and tolerance of electrical stimulation or intermittent pneumatic compression.
STATISTICAL METHODS This study utilized a repeated measures design with two within group factors: time to measurement, and stimulation (stimulation, control). Stimulation groups [electrical foot stimulation and intermittent pneumatic compression (IPC)] were not independent. Blood flow measurements (at time = 120, 240) were analyzed with t tests and a mixed model. Within the mixed model, the group effect is a fixed effect, and the subject parameter is a random effect. The primary research question was the non-inferiority of the experimental treatment (electrical foot stimulation) relative to standard treatment (intermittent pneumatic compression). The non-inferiority index was 5.0 cm/sec; this index was formulated prior to analysis. The questionnaire results were analyzed using Fisher's Exact test. P-values that were less than 0.05 were considered to be statistically significant. All analyses were done with SAS 9.1, Cary, NC.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| 1 | Experimental | Device: The Focus™ Neuromuscular Stimulation SystemElectrical foot stimulation |
Who may qualify
- Ages
- 50 to 80 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Healthy volunteers
Key exclusion criteria (7 listed)
- Venous or arterial disease of the lower limbs
- Cardiac pacemaker
- Known allergy to materials of surface electrodes
- Neurologic disorder
- Lower extremity fracture history
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| The Focus™ Neuromuscular Stimulation SystemElectrical foot stimulation was produced by surface electrodes placed on the sole of the foot over the plantar muscle group. Electrical stimulation was delivered by The Focus™ Neuromuscular Stimulation System, Empi, Inc. (St. Paul, MN.) The crucial stimulus parameters were: biphasic symmetrical square wave at 50 pulses per second, phase duration of 300 microseconds, a starting ramp up time of 2 seconds and a finishing ramp down time of 2 seconds per stimulation cycle, and a stimulation cycle of 12 seconds "on" and 48 seconds "off" per minute. Stimulation was increased to an intensity just sufficient to create a slight visible muscle twitch. This level of intensity caused no evident discomfort in any of the subjects in our first study. Subjects were continually monitored throughout this study for any indication of discomfort.The Focus™ Neuromuscular Stimulation System created electrical stimulation of the plantar foot muscles. | Device | 1 |
Primary outcome
Doppler venous blood flow velocity changes over 4 hours
Time frame: Two, 4 hour sessions
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 11 Mar 2008.
- Background: PubMed 12195689Kaplan RE, Czyrny JJ, Fung TS, Unsworth JD, Hirsh J. Electrical foot stimulation and implications for the prevention of venous thromboembolic disease. Thromb Haemost. 2002 Aug;88(2):200-4.
Related trials for Deep Vein Thrombosis
RecruitingPhase 3
Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers
Venous Thromboembolism (VTE)
RecruitingPhase 3
REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis
Cancer-Associated Thrombosis (CAT)
RecruitingPhase 3
REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants
Symptomatic Venous Thromboembolism (VTE)
Active, not recruiting
This Research Proposal Focuses on Evaluating the Effectiveness of a Nursing Care Protocol in Preventing Deep Vein Thrombosis (DVT) in Patients Undergoing On-pump Cardiac Surgery. The Study Will Include an Intervention Group That Receives the Nursing Protocol and a Control Group That Receives Routine
On-pump Cardiac Surgery - Prevention - Intervention - Experimental Group - Control Group - Incidence - Complications, DVT - Deep Vein Thrombosis
Recruiting
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
Venous Thromboembolism, Deep Venous Thrombosis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Robert E Kaplan, MD principal investigator
University at Buffalo School of Medicine and Biomedical Sciences
James J Czyrny, MD principal investigator
University at Buffalo School of Medicine and Biomedical Sciences
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 1 study testing The Focus™ Neuromuscular Stimulation System in people with Deep Vein Thrombosis and Pulmonary Embolism, run by University at Buffalo at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 11 Mar 2008. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Doppler venous blood flow velocity changes over 4 hours (time frame: Two, 4 hour sessions). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT00114608, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Mar 2008.